✅ Product Benefits

1. Dual-action glucose regulation
   Empagliflozin enhances urinary glucose excretion by inhibiting renal SGLT‑2, while metformin reduces hepatic glucose output and improves peripheral insulin sensitivity .

2. Support for cardiovascular risk reduction
   The SGLT‑2 component can reduce the risk of cardiovascular death in type 2 diabetes patients with established cardiovascular disease 

   Well-established metformin effects

3. Metformin contributes weight neutrality or modest loss, low hypoglycemia risk, and improved lipid profile 

4. Convenient dosing
   Immediate-release tablet taken twice daily with meals, with gradual titration to minimize GI discomfort .

5. Flexible dose transition
   Provides an easy switch from individual empagliflozin or metformin regimens with equivalent dosing for continuity 

6. Favorable safety and tolerability
   Common side effects include GI upset (metformin) and urogenital infections or dehydration (empagliflozin). Close monitoring is needed in renal or volume-depleted patients .

7. Guided renal precautions
   Contraindicated if eGFR <45 mL/min/1.73 m². Monitor renal function prior to initiation and during use .

8. Safe pregnancy/lactation use warning
   Not recommended during pregnancy or breastfeeding due to limited safety data and potential risks from both empagliflozin and metformin 

9. Widely available & affordable
   Pack size of 18 tablets: priced approx. ৳15–৳18 per tablet; available at pharmacies and online in Bangladesh